Epistem completes board line up and launches new NGS service
Epistem Limited, the Manchester based pre-clinical and clinical research services company announces the completion of its Board appointments. Investment from the Foresight group in June 2018 enabled expansion of the research services, the first of which is launched in December 2018 - GCLP compliant Next Generation Sequencing (NGS) services.
10 Years GCLP Accreditation at Epistem
We are pleased to announce the successful GCLP re-accreditation of our laboratories.
Epistem completes management buyout
Epistem, the Manchester UK-based Contract Research Company, announces that following investment by Foresight Group it has completed a management buy-out ("MBO") from genedrive plc.
11th World Congress and Expo on Cell & Stem Cell Research
March 25-26, 2019
Theme: Stem Cell Research- Hope against hype
AACR Annual Meeting 2019
March 29-03, 2019
Georgia World Congress Center, Atlanta, Georgia, USA
event item summary - edit
3rd Advances in Cell & Stem Cell Research Congress
September 25-26, 2019
World-renowned speakers, the most recent techniques, developments, and the newest updates from the field of Stem Cells and its applications are hallmarks of this conference